What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Cancer, Surgery, Gastrectomy, Internal medicine and Randomized controlled trial.
His Cancer study combines topics in areas such as Survival rate, Lymph node, Pathology and Stomach.
His Surgery study incorporates themes from Stomach cancer, Clinical trial, Early Gastric Cancer and Hazard ratio.
His Internal medicine research includes themes of Gastroenterology and Oncology.
His Gastroenterology research includes elements of Lymphatic system and Endoscopic mucosal resection.
In his study, which falls under the umbrella issue of Randomized controlled trial, Multivariate analysis, In situ hybridization and Receptor is strongly linked to Adjuvant.
His most cited work include:
- Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers (1380 citations)
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer (795 citations)
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis (574 citations)
What are the main themes of his work throughout his whole career to date?
Mitsuru Sasako mostly deals with Cancer, Internal medicine, Surgery, Gastrectomy and Oncology.
His studies deal with areas such as Randomized controlled trial, Lymph node, Pathology and Chemotherapy as well as Cancer.
His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Adenocarcinoma and other disciplines.
His Surgery study frequently draws connections between related disciplines such as Stomach.
His Gastrectomy research is multidisciplinary, incorporating perspectives in Prospective cohort study, Phases of clinical research, Early Gastric Cancer and General surgery.
The study incorporates disciplines such as Advanced gastric cancer and D2 gastrectomy in addition to Oncology.
He most often published in these fields:
- Cancer (70.32%)
- Internal medicine (47.74%)
- Surgery (42.26%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer (70.32%)
- Internal medicine (47.74%)
- Chemotherapy (18.06%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer, Internal medicine, Chemotherapy, Gastrectomy and Oncology.
His Cancer research is multidisciplinary, relying on both Stage, Incidence, Lymph node and Hazard ratio.
Internal medicine is closely attributed to Gastroenterology in his study.
Mitsuru Sasako interconnects Clinical trial and Invasion depth in the investigation of issues within Chemotherapy.
His Gastrectomy research incorporates elements of Hernia, Surgery, Prone position, Fascia and Clinical endpoint.
His work on Adjuvant as part of general Oncology study is frequently linked to Propagermanium, therefore connecting diverse disciplines of science.
Between 2017 and 2021, his most popular works were:
- A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A). (49 citations)
- Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. (46 citations)
- Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial (45 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Mitsuru Sasako mainly focuses on Internal medicine, Cancer, Chemotherapy, Gastrectomy and Clinical trial.
He regularly links together related areas like Gastroenterology in his Internal medicine studies.
The Chemotherapy study combines topics in areas such as Informed consent, Disease, Oncology and General surgery.
His Gastrectomy study combines topics from a wide range of disciplines, such as Clinical endpoint and Lymph node.
As a member of one scientific family, Mitsuru Sasako mostly works in the field of Clinical trial, focusing on Hazard ratio and, on occasion, Interim analysis, Intention-to-treat analysis, Survival rate and Surgery.
Mitsuru Sasako has included themes like Stomach cancer, Stomach and Total mesorectal excision in his Surgery study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
